Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumours

Author:

Bagrodia Aditya1ORCID,Savelyeva Anna1,Lafin John T.1,Speir Ryan W.2ORCID,Chesnut Gregory T.3,Frazier Anne Lindsay4,Woldu Solomon L.1,Margulis Vitaly15ORCID,Murray Matthew J.67ORCID,Amatruda James F.8,Lotan Yair1ORCID

Affiliation:

1. Department of Urology; University of Texas Southwestern Medical Center; Dallas TX USA

2. Madigan Army Medical Center; Joint Base Lewis-McChord; Tacoma WA USA

3. Walter Reed National Military Medical Center; Bethesda MD USA

4. Dana-Farber/Boston Children’s Cancer and Blood Disorder Center; Boston MA USA

5. Department of Urology; I.M. Sechenov First Moscow State University; Moscow Russia

6. Department of Pathology; University of Cambridge; Cambridge UK

7. Department of Pediatric Hematology and Oncology; Cambridge University Hospitals NHS Foundation Trust; Cambridge UK

8. Departments of Pediatrics and Medicine; Keck School of Medicine; Cancer and Blood Disease Institute; Children's Hospital Los Angeles; University of Southern California; Los Angeles CA USA

Funder

St. Baldrick’s Consortium Award

Cancer Prevention and Research Institute of Texas

Malignant Germ Cell International Consortium

Dedman Family Scholarship in Clinical Care

Publisher

Wiley

Subject

Urology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3